Chugai

Chugai falls foul of ABPI code for close consultant relationship

July 17, 2015
Medical Communications, Sales and Marketing ABPI Code, Chugai, PMCPA, Prescription Medicines Code of Practice Authority

Bosses at Chugai have been rapped by the industry’s code of practice regulator, after a senior manager failed to declare …

WHO flag

Novartis receives WHO nod for malaria drug Coartem

July 17, 2015
Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization

The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …

AstraZeneca

AstraZeneca receives US approval for Iressa

July 16, 2015
Medical Communications, Sales and Marketing AstraZeneca, FDA, Iressa, lung cancer, non-small cell lung cancer

AstraZeneca’s lung cancer therapy Iressa has been approved by the FDA – four years after the company pulled it from the …

It’s time the industry spoke out about legal challenge to clinical trial transparency

July 16, 2015
Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …

Industry awaits outcome of transparency legal challenge

July 16, 2015
Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …

ABPI

UK pharma made £41 million in doctor payments

July 16, 2015
Medical Communications, Sales and Marketing ABPI, ABPI Code, doctor payments

The pharma industry made £41m in payments to doctors, nurses and other healthcare professionals in the UK in 2014, the …

brandicourt

New Sanofi boss Brandicourt restructures global business

July 16, 2015
Sales and Marketing Oliver Brandicourt, Sanofi

Sanofi is reorganising its pharmaceuticals division to create three new business units from January 2016. Chief executive Oliver Brandicourt has …

Janssen sales follow J&J’s downward trend

July 15, 2015
Sales and Marketing J&J, JJ, Johnson & Johnson, Johnson and Johnson, financial results, olysio

Strong sales of its new hepatitis C treatment Olysio were not enough to stop a slump in profits at J&J’s …

Celgene

Celgene to acquire Receptos in $7.2bn deal

July 15, 2015
Sales and Marketing Celgene, Crohn's, Crohn’s disease, Receptos, acquisitions, crohn's disease, mergers, multiple sclerosis, ozanimod, relapsing multiple sclerosis, ulcerative colitis

Celgene has boosted its immune and inflammatory disease pipeline with the purchase of the biopharma company Receptos for $7.2 billion. …

MRC, GSK and universities team up on inflammatory diseases

July 15, 2015
Research and Development COPD, GSK, MRC, Medical Research Council, fibrosis, inflammatory diseases

UK pharma giant GSK is partnering with the Medical Research Council, to study the biological mechanisms behind common inflammatory diseases. …

anderw_mackie_picture

Ergomed strengthens management team and board

July 15, 2015
Research and Development, Sales and Marketing Andrew Mackie, ergomed

UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …

The Francis Crick Institute

GSK and the Francis Crick Institute collaborate on drug R&D

July 15, 2015
Research and Development Francis Crick Institute, GSK, R&D, The Crick, medical research

The UK’s largest pharma company and the UK’s newest biomedical research facility are partnering up to begin an innovation collaboration.The …

Public Health England

Public Health England and Imperial Innovations boost UK life sciences sector

July 14, 2015
Manufacturing and Production, Research and Development Imperial Innovations, Public Health England, R&D, investment, life sciences, spin-puts

The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …

Life sciences minister George Freeman

Government launches Accelerated Access Review call to action

July 14, 2015
Research and Development Accelerated Access Review, Sir Hugh Taylor, UK, george freeman, john bell, life sciences minister

The Government is urging pharma companies to participate in the Accelerated Access Review, and will launch a website for firms …

Rexulti (brexpiprazole)

FDA approves Lundbeck and Otsuka’s Rexulti for depression

July 14, 2015
Sales and Marketing FDA, Lundbeck, Otsuka, Rexulti, US, brexpiprazole, depression, major depressive disorder, schizophrenia

Lundbeck and Otsuka have gained a yes vote from the FDA for their jointly-marketed antidepressant, Rexulti. The US regulator approved …

Chancellor announces drug R&D funding boost in Catapult expansion

July 14, 2015
Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

Actavis facility in Iceland

Allergan closing manufacturing facility in Iceland

July 14, 2015
Manufacturing and Production Actavis, Allergan, Iceland, manufacturing, production, redundancies

Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …

Pharma companies look to Apple’s ResearchKit for R&D

July 13, 2015
Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit

Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …

Astellas' Ken Jones

Diary of a decade – Ten years in Europe, the Middle East and Africa

July 13, 2015
Medical Communications, Sales and Marketing Astellas, Ken Jones

It’s hard to imagine how much a company can change in a decade.When Astellas Pharma Europe was launched 10 years …

The Gateway to Local Adoption Series

Latest content